Mangoceuticals (MGRX) EBITDA Margin (2023 - 2026)
Mangoceuticals' (MGRX) quarterly EBITDA Margin came in at 5017.09% in Q1 2026, down 59660.0% year-on-year from N/an in Q1 2025, and down 135.52% quarter-over-quarter from 14126.2% in Q4 2025.
Mangoceuticals (MGRX) EBITDA Margin (2023 - 2026) Analysis & Trends
Mangoceuticals has disclosed EBITDA Margin across 4 years of filings, most recently posting 5017.09% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 5017.09%, down 59660.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 696.31% (up 14363.0% YoY), and the FY2025 annual result was 950.64%, down 65374.0% from the prior year.
- EBITDA Margin came in at 5017.09% for Q1 2026 at Mangoceuticals, down from 14126.2% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 14126.2% in Q4 2025 to a low of 8953.45% in Q3 2025.
- The 4-year median for EBITDA Margin is 1329.13% (2024), against an average of 989.04%.
- Peak annual rise in EBITDA Margin reached 988303 bps in 2025, while the deepest fall reached 763524 bps in 2025.
- Mangoceuticals' EBITDA Margin stood at 1050.87% in 2023, then soared by 504 bps to 4243.18% in 2024, then surged by 233 bps to 14126.2% in 2025, then sank by 136 bps to 5017.09% in 2026.
- The last three EBITDA Margin figures came in at 5017.09% (Q1 2026), 14126.2% (Q4 2025), and 8953.45% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 26.39% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 29.03% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 19.09% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -11.30% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 17.08% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 27.87% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 1.25% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 5.44% |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | -5,017.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,017.09% |
| Dec 31, 2025 | 14,126.20% |
| Sep 30, 2025 | -8,953.45% |
| Jun 30, 2025 | -3,133.98% |
| Mar 31, 2025 | -4,420.49% |
| Dec 31, 2024 | 4,243.18% |
| Sep 30, 2024 | -1,318.21% |
| Jun 30, 2024 | -1,329.13% |
| Mar 31, 2024 | -1,105.87% |
| Dec 31, 2023 | -1,050.87% |
| Sep 30, 2023 | -733.99% |
| Jun 30, 2023 | -1,622.99% |
| Mar 31, 2023 | -2,540.78% |